Former President · Heron Therapeutics, Inc. (HRTX)

Robert Rosen

A named executive officer of Heron Therapeutics in every fiscal year CompBrief holds from FY2016 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,101,031

Salary $78,645Stock awards $0

FY2018: $5,983,047

5th of 5 named executive officers at Heron Therapeutics by FY2019 total.

5 named officers on file for Heron Therapeutics, FY2019

Robert Rosen’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • HRTX’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Heron Therapeutics’s whole pay program stands against its peers

  • Heron Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on HRTX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2020 (DEF 14A).

Free

Get Robert Rosen’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Robert Rosen compensation by year

Heron Therapeutics Summary Compensation Table · all 4 fiscal years held
In US dollars, as Heron Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019
Salary$579,143$596,518$614,414$78,645
Bonus$0$0$0$0
Stock awards$0$0$0$0
Option awards$2,976,744$3,391,524$4,815,660$0
Non-equity incentive$208,492$246,958$552,973$0
Pension and deferred compensation$0$0$0$0
All other$0$0$0$1,022,386
Total$3,764,379$4,235,000$5,983,047$1,101,031

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Heron Therapeutics, Inc. DEF 14A filed April 23, 2020, accession 0001564590-20-018187, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Heron Therapeutics, Inc. filed document, accession 0001564590-20-018187. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2020.

$3.8M
$4.2M
$6.0M
$1.1M
FY16
FY17
FY18
FY19
SalaryNon-equity incentiveOption awardsAll other

Heron Therapeutics’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Barry QuartChief Executive Officer$5,870,479
John PoyhonenExecutive Vice President, Chief Commercial Officer$4,524,764
Kimberly ManhardExecutive Vice President, Drug Development$2,509,866
Robert HoffmanFormer Chief Financial Officer and Senior Vice President, Finance$2,034,232
Robert Rosen · this pageFormer President$1,101,031

The full Heron Therapeutics compensation record

free company brief

This page is one person within Heron Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Heron Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Robert Rosen's compensation dossier · One-time report. No refunds.